Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features

PLoS ONE
Multidisciplinary
2017English

Disparities in the Treatment of Patients With IL-2 for Metastatic Renal Cell Carcinoma

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2010English

Intravenous Interleukin-2 in Patients Over 65 With Metastatic Renal Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1992English

A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

British Journal of Cancer
Cancer ResearchOncology
1996English

Sorafenib With Interleukin-2 vs Sorafenib Alone in Metastatic Renal Cell Carcinoma: The ROSORC Trial

British Journal of Cancer
Cancer ResearchOncology
2011English

Two Randomised Phase II Trials of Subcutaneous Interleukin-2 and Histamine Dihydrochloride in Patients With Metastatic Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2005English

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Perioperative Immunomodulation With Interleukin-2 in Patients With Renal Cell Carcinoma: Results of a Controlled Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2006English

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy